Previous 10 | Next 10 |
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this Read more ...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings a...
NEW YORK , March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Washington Real Estate Investment Trust (NYSE: WRE) will replace Investment Technology Group Inc. (NYSE: ITG) prior to the open of trading on Thursday, March...
Washington Real Estate Investment (NYSE: WRE ) has risen 5.8% after hours on word that it's moving into the S&P SmallCap 600 . More news on: Washington Real Estate Investment, Investment Technology Group Inc., Cardiovascular Systems, Inc., Financial stocks news, Healthcare stocks ne...
Quick Take Shockwave Medical ( SWAV ) intends to raise $75 million from the sale of its common stock, per an amended registration statement . The company sells medical instruments to assist in removing calcified plaque in arteries and peripheral blood vessels. SWAV is growing quickly fr...
On Wednesday, February 27, 2019, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8 th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. Eastern Time. You m...
Quick Take Shockwave Medical ( SWAV ) intends to raise gross proceeds of $70 million from a U.S. IPO, according to an S-1 registration statement . The firm has developed a sonic wave catheter system for the treatment of calcified plaque. SWAV seeks public capital to fund commercializati...
Cardiovascular Systems, Inc. (CSII) Q2 2019 Results Earnings Conference Call January 30, 2019, 4:30 pm ET Company Participants Jack Nielsen - Vice President of Investor Relations and Corporate Communications Scott Ward - Chairman, President, Chief Executive Officer Jeff Points - ...
Cardiovascular Systems (NASDAQ: CSII ) fiscal Q2 results ($M): Revenues: 60.2 (+14.4%). More news on: Cardiovascular Systems, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Conference Call Scheduled for Today, January 30, 2019, at 3:30 PM CT (4:30 PM ET) Revenues of $60.2 million increased 14.4% from second quarter last year Net income was $0.5 million, or $0.01 per diluted share Company reiterates fiscal 2019 revenue guidance Orbita...
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...